Informations générales (source: ClinicalTrials.gov)
Osse Registry for Patients With Lipodystrophy Run by the European Consortium of Lipodystrophies (ECLip)
Observational [Patient Registry]
University of Ulm (Voir sur ClinicalTrials)
décembre 2017
janvier 2068
02 décembre 2025
Given the lack of knowledge on lipodystrophies, the medical and social responsibility for
the persons affected by it calls for the monitoring of the progression over long periods
of time. Sensible clinical and basic research into rare diseases such as lipodystrophy is
only possible in multi-location networks with sufficient case numbers. Also, reliable
information on the incidence of certain manifestation patterns, health status, etc. is of
utmost importance for health care and health policy in this rare disease.
Therefore, the European Consortium of Lipodystrophies (ECLip), an association of European
experts on lipodystrophy, has launched a registry (OSSE) for lipodystrophies which is
committed to help to improve the research conditions by consolidating this kind of
information in a registry.
Etablissements
| Etablissement | Contact | Statut | Actualisé | ||
|---|---|---|---|---|---|
| Etablissement non spécifié, référez vous à la page NCT pour plus d'information Origine et niveau de fiabilité des données | |||||
Critères
Tous
- lipodystrophy
Exclusion Criteria:
- lipodystrophy due to anti-retroviral drugs